LIGAND PHARMACEUTICALS INCORPORATED Derivative Asset, Noncurrent
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Derivative Asset, Noncurrent of $17.91 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DerivativeAssetsNoncurrent · last filed 2026-08-07
- 2026-06-30: Derivative Asset, Noncurrent $17.91M.
- 2026-03-31: Derivative Asset, Noncurrent $13.53M.
- 2025-12-31: Derivative Asset, Noncurrent $15.63M.
- 2025-09-30: Derivative Asset, Noncurrent $9.35M.
| Period end | Derivative Asset, Noncurrent |
|---|---|
| 2026-06-30 | $17.91M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $13.53M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $15.63M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $9.35M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $17.96M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $18.03M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $10.58M 10-K · filed 2026-02-27 |
| 2024-09-30 | $19.25M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $34.51M 10-Q · filed 2024-08-07 |
| 2023-12-31 | $3.53M 10-K · filed 2025-02-28 |
| 2023-09-18 | $3.20M 10-K · filed 2026-02-27 |